Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis - PubMed (original) (raw)
Comparative Study
. 1993 Feb;204(2):356-63.
doi: 10.1006/excr.1993.1043.
Affiliations
- PMID: 7679998
- DOI: 10.1006/excr.1993.1043
Comparative Study
Biphasic effect of transforming growth factor-beta 1 on in vitro angiogenesis
M S Pepper et al. Exp Cell Res. 1993 Feb.
Abstract
Although the existence of an increasing number of angiogenesis-regulating cytokines is well documented, the response elicited by combinations of these cytokines is largely unknown. Using an in vitro model in which microvascular endothelial cells can be induced to form capillary-like tubes within three-dimensional collagen or fibrin gels, we have investigated the effect of transforming growth factor-beta 1 (TGF-beta 1) on basic fibroblast growth factor (bFGF)-induced and vascular endothelial growth factor (VEGF)-induced angiogenesis. Endothelial cell invasion and capillary lumen formation were inhibited by TGF-beta 1 at relatively high concentrations (5-10 ng/ml), while lower concentrations (100 pg/ml-1 ng/ml) of TGF-beta 1 potentiated the effect of bFGF- and VEGF-induced invasion. The optimal potentiating effect was observed at 200-500 pg/ml TGF-beta 1. At invasion-potentiating doses of TGF-beta 1, lumen size in fibrin gels was markedly reduced compared to that in cultures treated with bFGF alone. These results show that TGF-beta 1 exerts a biphasic effect on bFGF- and VEGF-induced angiogenesis in vitro. Our studies support the notion that the nature of the angiogenic response elicited by a specific cytokine is contextual, i.e., depends on the presence and concentration of other cytokines in the pericellular environment of the responding endothelial cell.
Similar articles
- Basic fibroblast growth factor and transforming growth factor beta-1: synergistic mediators of angiogenesis in vitro.
Gajdusek CM, Luo Z, Mayberg MR. Gajdusek CM, et al. J Cell Physiol. 1993 Oct;157(1):133-44. doi: 10.1002/jcp.1041570118. J Cell Physiol. 1993. PMID: 7691833 - Vascular endothelial growth factor (VEGF)-C synergizes with basic fibroblast growth factor and VEGF in the induction of angiogenesis in vitro and alters endothelial cell extracellular proteolytic activity.
Pepper MS, Mandriota SJ, Jeltsch M, Kumar V, Alitalo K. Pepper MS, et al. J Cell Physiol. 1998 Dec;177(3):439-52. doi: 10.1002/(SICI)1097-4652(199812)177:3<439::AID-JCP7>3.0.CO;2-2. J Cell Physiol. 1998. PMID: 9808152 - Synergistic effect of hyaluronan oligosaccharides and vascular endothelial growth factor on angiogenesis in vitro.
Montesano R, Kumar S, Orci L, Pepper MS. Montesano R, et al. Lab Invest. 1996 Aug;75(2):249-62. Lab Invest. 1996. PMID: 8765325 - Endothelial cell regulation by transforming growth factor-beta.
RayChaudhury A, D'Amore PA. RayChaudhury A, et al. J Cell Biochem. 1991 Nov;47(3):224-9. doi: 10.1002/jcb.240470307. J Cell Biochem. 1991. PMID: 1724244 Review. - Growth factor control of extracellular proteolysis.
Rifkin DB, Moscatelli D, Bizik J, Quarto N, Blei F, Dennis P, Flaumenhaft R, Mignatti P. Rifkin DB, et al. Cell Differ Dev. 1990 Dec 2;32(3):313-8. doi: 10.1016/0922-3371(90)90045-x. Cell Differ Dev. 1990. PMID: 1711916 Review.
Cited by
- Phytochemicals Showing Antiangiogenic Effect in Pre-clinical Models and their Potential as an Alternative to Existing Therapeutics.
Senrung A, Tripathi T, Aggarwal N, Janjua D, Yadav J, Chaudhary A, Chhokar A, Joshi U, Bharti AC. Senrung A, et al. Curr Top Med Chem. 2024;24(4):259-300. doi: 10.2174/0115680266264349231016094456. Curr Top Med Chem. 2024. PMID: 37867279 Review. - Lupus podocytopathy superimposed on diabetic glomerulosclerosis: A case report.
Liu L, Murray B, Tomaszewski JE. Liu L, et al. Medicine (Baltimore). 2021 Sep 17;100(37):e27077. doi: 10.1097/MD.0000000000027077. Medicine (Baltimore). 2021. PMID: 34664831 Free PMC article. - TGF-β links glycolysis and immunosuppression in glioblastoma.
Gong L, Ji L, Xu D, Wang J, Zou J. Gong L, et al. Histol Histopathol. 2021 Nov;36(11):1111-1124. doi: 10.14670/HH-18-366. Epub 2021 Jul 29. Histol Histopathol. 2021. PMID: 34323284 Review. - Pulmonary Vascular Complications in Hereditary Hemorrhagic Telangiectasia and the Underlying Pathophysiology.
Bofarid S, Hosman AE, Mager JJ, Snijder RJ, Post MC. Bofarid S, et al. Int J Mol Sci. 2021 Mar 27;22(7):3471. doi: 10.3390/ijms22073471. Int J Mol Sci. 2021. PMID: 33801690 Free PMC article. Review. - Syndecan-1 Overexpressing Mesothelioma Cells Inhibit Proliferation, Wound Healing, and Tube Formation of Endothelial Cells.
Javadi J, Heidari-Hamedani G, Schmalzl A, Szatmári T, Metintas M, Aspenström P, Hjerpe A, Dobra K. Javadi J, et al. Cancers (Basel). 2021 Feb 6;13(4):655. doi: 10.3390/cancers13040655. Cancers (Basel). 2021. PMID: 33562126 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources